RT Journal Article
SR Electronic
T1 Promising integrated care platform developed with and tested by respiratory patients: lessons learned form the European H2020 Connecare study
JF European Respiratory Journal
JO Eur Respir J
FD European Respiratory Society
SP 4800
DO 10.1183/13993003.congress-2020.4800
VO 56
IS suppl 64
A1 Metting, Esther I.
A1 Lahr, Maarten M.H.
YR 2020
UL http://erj.ersjournals.com/content/56/suppl_64/4800.abstract
AB Background: The Connecare project aims to develop a smart adaptive integrated care platform for chronic disease management. The platform aims to support healthcare providers (HCP) managing chronically ill patients. Communication between HCP can be facilitated and patients self-management will be stimulated through the system. The developed prototype includes a dashboard for health care providers and an app for patients. In this study we describe the development of the app for respiratory patients.Methods: Patients with asthma and COPD cyclically evaluated the prototype that was connected with a Fitbit. Their opinions were used by the IT technicians for improvement. We evaluated log data of the prototype tested in 6 months follow-up. The usability of using motivating messages regarding physical activity was tested using the System Usability Scale (SUS).Method: The app was adapted according to the remarks of the patients. Especially the layout needed improvement. Patients who used the app for 6 months (n=46, mean age 60±13, range 31-82, 52% male, 30% asthma, 65% COPD, 4% ACO) ncould not install the app by themselves but were able to use the app after installation. Many patients used phones too old for the app. Three patients felt stressed when using the app and dropped out. The app was considered to be user friendly (SUS: 82%±16). Sending motivational messages did not improve the average step count.Method: The Connecare prototype improved substantially based on patients’ feedback. However, patients need support when installing and linking the prototype with the Fitbit. The prototype is ready for further development and implementation.FootnotesCite this article as: European Respiratory Journal 2020; 56: Suppl. 64, 4800.This abstract was presented at the 2020 ERS International Congress, in session “Respiratory viruses in the "pre COVID-19" era”.This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).